Navidea Biopharmaceuticals Inc (OP: NAVB )

0.0010 +0.0005 (+100.00%)
Streaming Delayed Price Updated: 10:36 AM EST, Nov 8, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
December 18, 2012
Form 8-K
Source: SEC/Edgar
December 02, 2012
Form 8-K/A
Source: SEC/Edgar
November 13, 2012
Form 8-K
Source: SEC/Edgar
November 12, 2012
Form 8-K
Source: SEC/Edgar
November 08, 2012
Form 8-K
Source: SEC/Edgar
October 31, 2012
Form 424B3
Source: SEC/Edgar
October 21, 2012
Form EFFECT
Source: SEC/Edgar
October 16, 2012
Form 8-K
Source: SEC/Edgar
October 10, 2012
Form S-3/A
Source: SEC/Edgar
October 10, 2012
Form S-3
Source: SEC/Edgar
September 27, 2012
Form CT ORDER
Source: SEC/Edgar
September 26, 2012
Form 8-K
Source: SEC/Edgar
September 20, 2012
Form 8-K
Source: SEC/Edgar
September 11, 2012
Form 8-K
Source: SEC/Edgar
September 05, 2012
Form POS AM
Source: SEC/Edgar
August 29, 2012
Form EFFECT
Source: SEC/Edgar
August 29, 2012
Form 8-K
Source: SEC/Edgar
August 29, 2012
Form EFFECT
Source: SEC/Edgar
August 29, 2012
Form POS AM
Source: SEC/Edgar
August 29, 2012
Form 8-K
Source: SEC/Edgar
August 19, 2012
Form S-8
Source: SEC/Edgar
August 14, 2012
Form 8-K
Source: SEC/Edgar
August 06, 2012
Form 8-K
Source: SEC/Edgar
August 05, 2012
Form 8-K
Source: SEC/Edgar
July 30, 2012
Form SC 13G
Source: SEC/Edgar
July 26, 2012
Form ARS
Source: SEC/Edgar
July 10, 2012
Form DEF 14A
Source: SEC/Edgar
July 09, 2012
Form 8-K
Source: SEC/Edgar
June 06, 2012
Form SC 13D/A
Source: SEC/Edgar
June 03, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.